NCT07287033

Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy

RecruitingPHASE1INTERVENTIONAL

Trial Details

Start: 2025-12-06Est. Completion: 2027-04

Enrollment target: 48 participants

Locations

Arkansas Children's Hospital and Research Institute, Little Rock, Arkansas, United States
Children's Hospital Colorado, Aurora, Colorado, United States
Asthma and Allergy Associates, PC, Colorado Springs, Colorado, United States
Syneos Health Clinical Research Services LLC, Miami, Florida, United States
University of South Florida, Tampa, Florida, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Mary H. Weiser Food Allergy Center (MHWFAC) University of Michigan - Michigan Medicine, Ann Arbor, Michigan, United States
Children's Health, Dallas, Texas, United States
Texas Children's Hospital/Baylor College of Medicine, Houston, Texas, United States

Peanut Allergic SubjectsPeanut AllergiesPeanut HypersensitivityFood Allergy PeanutFood Allergy in ChildrenFood Allergies

This clinical trial aims to investigate if oral immunotherapy can help children with peanut allergy tolerate peanut. Ch…

Aarhus, DenmarkEst. completion Oct 2030

Allergy

This is a multi-center, mechanistic study. It is designed to learn more about signs in the body, called biomarkers, that…

Little Rock, United StatesEst. completion Dec 1, 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.